GLUE (GLUE) Stock Price & Analysis
GLUE (GLUE) fell 3.75% to USD 13.84 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
GLUE last closed at USD 13.84; the session ranged USD 13.79–14.31 on volume of 804,585 shares. Market capitalization is —, with a 52-week range of USD 4.79–25.77 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 13.84 |
|---|---|
| Change | ▼ 3.75% (down) |
| Previous Close | USD 13.84 |
| Open | USD 13.84 |
| Day Range | USD 13.79 – 14.31 |
| 52-Week Range | USD 4.79 – 25.77 |
| Volume | 804,585 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (GLUE)
Nexqual's technical model rates GLUE "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.98 (oversold) |
| vs SMA50 | Below (USD 19.01) |
| MACD | -1.25 (negative) |
From GLUE's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | USD 2.11 | ▲ 0% |
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| ERAS | Erasca, Inc. | USD 16.19 | ▼ 1.1% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.